A low omega-6 polyunsaturated fatty acid (n-6 PUFA) diet increases omega-3 (n-3) long chain PUFA status in plasma phospholipids in humans

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 90, Issue 4, 2014, Pages 133-138

  Wood, K E ^a,c   Lau, A ^a   Mantzioris, E ^b   Gibson, R A ^c   Ramsden, C E ^d   Muhlhausler, B S ^c  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

ALA; Diet; Linoleic acid (LA); Omega 3 PUFA; Omega 6 PUFA

Indexed keywords

LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; ERYTHROCYTE; FAT INTAKE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID COMPOSITION; MACRONUTRIENT; MALE; NORMAL HUMAN; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; DIET; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; DIET; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LINOLEIC ACID; MALE; MIDDLE AGED; PHOSPHOLIPIDS; YOUNG ADULT;

EID: 84896402675     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.12.010     Document Type: Article

References (33)

1. Simopoulos A. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol. Neurobiol. 2011, 44:203-215.
2. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93:950-962.
3. Ghosh S., Novak E.M., Innis S.M. Cardiac proinflammatory pathways are altered with different dietary n-6 linoleic to n-3 α-linolenic acid ratios in normal, fat-fed pigs. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2919-H2927.
4. Ailhaud G., Massiera F., Weill P., Legrand P., Alessandri J.M., Guesnet P. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog. Lipid Res. 2006, 45:203-236.
5. Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler Thromb. Vasc. Biol. 2011, 31:986-1000.
6. Patterson E., Wall R., Fitzgerald G.F., Ross R.P., Stanton C. Health implications of high dietary omega-6 polyunsaturated fatty acids. J. Nutr. Metab. 2012, 2012:16.
7. Ramsden C.E., Zamora D., Leelarthaepin B., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. Br. Med. J. 2013, 346.
8. Sprecher H., Luthria D.L., Mohammed B.S., Baykousheva S.P. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J. Lipid Res. 1995, 36:2471-2477.
9. Lands W.E., Morris A., Libelt B. Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids 1990, 25:506-516.
10. Wada M., DeLong C.J., Hong Y.H., et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 2007, 282:22254-22266.
11. Serhan C.N., Arita M., Hong S., Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004, 39:1125-1132.
12. Serhan C.N., Gotlinger K., Hong S., et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol. 2006, 176:1848-1859.
13. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757. for the Nutrition Committee.
14. Howe P., Meyer B., Record S., Baghurst K. Dietary intake of long-chain ω-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 2006, 22:47-53.
15. Jenkins D.J.A., Sievenpiper J.L., Pauly D., Sumaila U.R., Kendall C.W.C., Mowat F.M. Are dietary recommendations for the use of fish oils sustainable?. Can. Med. Assoc. J. 2009, 180:633-637.
16. Wood K.E., Mantzioris E., Gibson R.A., Muhlhausler B.S. Incorporating macadamia oil and butter to reduce dietary omega-6 polyunsaturated fatty acid intake. Nutr. Diet 2013, 70:94-100.
17. Dietary Guidelines for Australian Adults - A Guide to Healthy Eating 2003, National Health and Medical Research Council (NHMRC), Commonwealth of Australia.
18. Macintosh B.A., Ramsden C.E., Faurot K.R., et al. Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research. Br. J. Nutr. 2013, 110:559-568.
19. Gibson R.A., Neumann M.A. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur. J. Clin. Nutr. 1997, 51:578-584.
20. Broekhuyse R. Improved lipid extraction of erythrocytes. Clin. Chim. Acta 1974, 51(3):341-343.
21. Tu W.C., Mühlhäusler B.S., Yelland L.N., Gibson R.A. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88:53-60.
22. Cleland L., James M., Neumann M., D'Angelo M., Gibson R. Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am. J. Clin. Nutr. 1992, 55:395-399.
23. Mantzioris E. Modification of the n-6:n-3 Polyunsaturated Fatty Acid Ratio in Human Tissues 1995, Flinders University of South Australia, Adelaide, Australia.
24. Arab L. Biomarkers of fat and fatty acid intake. J. Nutr. 2003, 133:S925-S932S.
25. Thompson F., Byers T. Dietary assessment resource manual. J. Nutr. 1994, 124(Suppl. 11):2245S-2317S.
26. Ramsden C.E., Ringel A., Feldstein A.E., et al. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot. Essent. Fatty Acids 2012, 87:135-141.
27. Feldstein A.E., Lopez R., Tamimi T.A.-R., et al. Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Lipid Res. 2010, 51:3046-3054.
28. Mabalirajan U., Rehman R., Ahmad T., et al. Linoleic acid metabolite drives severe asthma by causing airway epithelial injury. Sci. Rep. 2013, 3.
29. Ozawa T., Hayakawa M., Takamura T., et al. Biosynthesis of leukotoxin, 9, 10-epoxy-12 octadecenoate, by leukocytes in lung lavages of rat after exposure to hyperoxia. Biochem. Biophys. Res. Commun. 1986, 134:1071-1078.
30. Kosaka K., Suzuki K., Hayakawa M., Sugiyama S., Ozawa T. Leukotoxin, a linoleate epoxide: its implication in the late death of patients with extensive burns. Mol. Cell Biol. 1994, 139:141-148.
31. Patwardhan A.M., Akopian A.N., Ruparel N.B., et al. Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J. Clin. Invest. 2010, 120:1617.
32. Patwardhan A.M., Scotland P.E, Akopian A.N., Hargreaves K.M. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc. Natl. Acad. Sci. 2009, 106:18820-18824.
33. Ramsden C.E., Faurot K.R., Zamora D., et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain 2013, 154:2441-2451.